Clinical Trial Update: Combination of Transcatheter Arterial Chemoembolization (TACE) and Sorafenib for Patients With Unresectable Hepatocellular Carcinoma (HCC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating transarterial chemoembolization plus sorafenib for unresectable hepatocellular carcinoma has completed. No efficacy results are provide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: COMPLETED